Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

Acta Neuropathologica

Volumn 125, Issue 6, 2013, Pages 913-916

  Hovestadt, Volker ^a   Remke, Marc ^b,c   Kool, Marcel ^a   Pietsch, Torsten ^d   Northcott, Paul A ^a   Fischer, Roger ^a   Cavalli, Florence M G ^b   Ramaswamy, Vijay ^b,c   Zapatka, Marc ^a   Reifenberger, Guido ^e   Rutkowski, Stefan ^f   Schick, Matthias ^a   Bewerunge Hudler, Melanie ^a   Korshunov, Andrey ^a,g   Lichter, Peter ^a   Taylor, Michael D ^b,c   Pfister, Stefan M ^a,h   Jones, David T W ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF BONN   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN INHIBITOR; PROTEIN P53; SMOOTHENED PROTEIN; SMOOTHENED PROTEIN INHIBITOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI2; TUMOR MARKER; UNCLASSIFIED DRUG; WNT PROTEIN;

BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER MOLECULAR SUBGROUPING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; COPY NUMBER VARIATION; DNA METHYLATION; FAMILIAL CANCER; FROZEN SECTION; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC VARIABILITY; GENOME; GENOTYPE; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LETTER; MEDULLOBLASTOMA; MOLECULAR PROBE; MOLECULARLY TARGETED THERAPY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPORT VECTOR MACHINE; TISSUE SECTION; TREATMENT PLANNING; VALIDATION PROCESS;

CEREBELLAR NEOPLASMS; DNA METHYLATION; HUMANS; MEDULLOBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84878588603     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-013-1126-5     Document Type: Letter

References (15)

1. Gajjar A, Stewart CF, Ellison DW et al (2010) A phase I pharmacokinetic trial of sonic hedgehog (SHH) antagonist GDC-0449 in pediatric patients with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study (PBTC 25). J Clin Oncol 28(18s):Abstr. CRA9501
2. Geoerger B, Aerts I, Casanova M et al (2012) A phase I/II study of LDE225, a smoothened (Smo) antagonist, in pediatric patients with recurrent medulloblastoma (MB) or other solid tumors. J Clin Oncol 30(Suppl.):Abstr. 9519
3. Jones DTW, Jager N, Kool M et al (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature 488(7409):100-105. doi: 10.1038/nature11284
4. Kool M, Korshunov A, Remke M et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 123(4):473-484. doi: 10.1007/s00401-012-0958- 8
5. Kulis M, Heath S, Bibikova M et al (2012) Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet 44(11):1236-1242. doi: 10.1038/ng.2443
6. Northcott PA, Jones DTW, Kool M et al (2012) Medulloblastomics: the end of the beginning. Nat Rev Cancer 12(12):818-834. doi: 10.1038/nrc3410
7. Northcott PA, Korshunov A, Witt H et al (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29(11):1408-1414. doi: 10.1200/JCO.2009.27.4324
8. Northcott PA, Shih DJ, Peacock J et al (2012) Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488(7409):49-56. doi: 10.1038/nature11327
9. Northcott PA, Shih DJ, Remke M et al (2012) Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol 123(4):615-626. doi: 10.1007/s00401-011-0899-7
10. Noushmehr H, Weisenberger DJ, Diefes K et al (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17(5):510-522. doi: 10.1016/j.ccr.2010.03.017
11. Rausch T, Jones DTW, Zapatka M et al (2012) Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148(1-2):59-71. doi: 10.1016/j.cell.2011.12.013
12. Schwalbe EC, Williamson D, Lindsey JC et al (2013) DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol 125(3):359-371. doi: 10.1007/s00401-012-1077-2
13. Stephens PJ, Greenman CD, Fu B et al (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144(1):27-40. doi: 10.1016/j.cell.2010.11.055
14. Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425-437. doi: 10.1016/j.ccr.2012.08.024
15. Taylor MD, Northcott PA, Korshunov A et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123(4):465-472. doi: 10.1007/s00401-011-0922-z